VolitionRx Limited Schedules Third Quarter 2025 Earnings Conference Call and Business Update

Rhea-AI Summary

VolitionRx (NYSE AMERICAN: VNRX) will host its Third Quarter 2025 earnings and business update conference call on Friday, November 14, 2025 at 8:30 a.m. U.S. Eastern Time (2:30 p.m. Central European Time).

The call will be hosted by Louise Batchelor, Group Chief Marketing & Communications Officer, with Cameron Reynolds, President and Group CEO; Terig Hughes, Group CFO; and Dr. Jake Micallef, Chief Scientific Officer, discussing Q3 2025 financial and operating results and upcoming milestones.

Dial-in numbers, Conference ID 13757129, a live audio webcast link, and a telephone replay available through November 28, 2025 are provided for investors and analysts.

News Market Reaction

+0.56%

1 alert

+0.56% News Effect

On the day this news was published, VNRX gained 0.56%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Conference call to take place on Friday, November 14 at 8:30 a.m. U.S. Eastern Time

HENDERSON, Nev., Nov. 10, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announces that it will host a conference call on Friday, November 14 at 8.30 a.m. U.S. Eastern Time to discuss its financial and operating results for the third quarter of 2025 and to provide a business update. Details of this event can be found below.

Event:   VolitionRx Limited Third Quarter 2025 Earnings and Business Update Conference Call 
Date:     Friday, November 14, 2025
Time:    8:30 a.m. U.S. Eastern Time/2.30 p.m. Central European Time

U.S. & Canada Dial-in: 1-877-407-9716 (toll free)
U.K. Dial-in: 0 800 756 3429 (toll free)
Toll/International: 1-201-493-6779
Conference ID:  13757129

Louise Batchelor, Group Chief Marketing & Communications Officer will host the call along with Cameron Reynolds, President and Group Chief Executive Officer of Volition, Terig Hughes, Group Chief Financial Officer and Dr. Jake Micallef, Chief Scientific Officer. The call will provide an update on important events that have taken place in the third quarter of 2025 and upcoming milestones.

A live audio webcast of the conference call will also be available on this link. In addition, a telephone replay of the call will be available until November 28, 2025. The replay dial-in numbers are 1-844-512-2921 (toll-free) in the U.S. and Canada and 1-412-317-6671 (toll) internationally. Please use replay pin number 13757129.

About Volition

Volition is a multi-national company focused on advancing the science of epigenetics. Volition is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, disease and treatment monitoring.

Through its subsidiaries, Volition is developing and commercializing simple, easy to use, cost-effective blood tests to help detect and monitor a range of diseases, including some cancers and diseases associated with NETosis, such as sepsis. Early detection and monitoring have the potential to not only prolong the life of patients, but also to improve their quality of life.

Volition's research and development activities are centered in Belgium, with an innovation laboratory and office in the U.S. and an office in London.

The contents found at Volition's website address are not incorporated by reference into this document and should not be considered part of this document.  Such website address is included in this document as an inactive textual reference only.

Media Enquiries:
Louise Batchelor, Volition, mediarelations@volition.com +44 (0)7557 774620

Investor Relations
Jeremy Feffer, LifeSci Advisors, jfeffer@lifesciadvisors.com +1-212-915-2568

 

View original content:https://www.prnewswire.com/news-releases/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update-302610111.html

SOURCE VolitionRx Limited

FAQ

When is VolitionRx (VNRX) holding its Third Quarter 2025 earnings call?

The call is scheduled for Friday, November 14, 2025 at 8:30 a.m. U.S. Eastern Time.

Who will speak on VolitionRx's (VNRX) Q3 2025 conference call?

Speakers include Louise Batchelor, Cameron Reynolds (President & Group CEO), Terig Hughes (Group CFO) and Dr. Jake Micallef (CSO).

How can investors join the VolitionRx (VNRX) November 14, 2025 call by phone?

U.S. & Canada dial 1-877-407-9716 (toll free), U.K. dial 0 800 756 3429 (toll free), or international 1-201-493-6779 using Conference ID 13757129.

Will VolitionRx (VNRX) provide a webcast and replay for the Q3 2025 call?

Yes. A live audio webcast link will be available and a telephone replay is accessible until November 28, 2025 using replay pin 13757129.

What topics will VolitionRx (VNRX) cover on the November 14, 2025 call?

The company will discuss its Q3 2025 financial and operating results and provide a business update on recent events and upcoming milestones.